Edit

ELIXIR accelerates

ELIXIR has been awarded €19 million from the EU to accelerate the implementation of Europe’s life-science data infrastructure over the next four years. From September 2015, ‘ELIXIR-EXCELERATE’ will facilitate the integration of Europe’s bioinformatics resources, supporting all sectors of life-science R&D. It will deliver excellence to ELIXIR’s users by fast-tracking the development and deployment of essential data services.

EXCELERATE funding will help ELIXIR coordinate and extend national and international data resources to ensure the delivery of world-leading life-science data services. It will support a pan-European training programme, anchored in national infrastructures, to increase bioinformatics capacity and competency. It will also provide efficiencies in management and operation throughout the infrastructure, which is distributed amongst 17 countries.

ELIXIR Director Niklas Blomberg says, “I am delighted that the EU is supporting this high-impact project. In the age of big data, it is critical that we can all make the most of the bioinformatics capacity that has been developed in each of our member states. This will make a difference to Europe’s 500,000 life-science researchers, who need public research data to be managed well over the long term so it can be reused to maximum effect. EXCELERATE will bring about a step change in how bioinformatics services are coordinated across Europe, ensuring they are integrated, grow in step with the advent of new technologies, and maintained appropriately over the long term.”

This will make a difference to Europe’s 500,000 life-science researchers, who need public research data to be managed well over the long term

Dedicated use cases, defined in close partnership with diverse research communities, will help ELIXIR grow in keeping with the needs of scientists working on rare diseases, biomedical and human genomics, marine and plant sciences and other specialized areas. This will ensure that ELIXIR’s services for data, tools, interoperability, compute, training and industry support are rooted in user needs, and can deliver benefits to existing and future research projects.


About ELIXIR-EXCELERATE:

ELIXIR was invited to apply to a dedicated call within Horizon 2020 following the ESFRI and European Council decision in 2014 to categorize ELIXIR as one of Europe’s three priority new Research Infrastructures. ELIXIR-EXCELERATE represents ELIXIR’s submission to this Call.

Tags: Bioinformatics, Databases, ELIXIR, EMBL-EBI, Partnerships, rare diseases

More from this category

Picture of the week

It’s almost a year since the coronavirus outbreak was declared a pandemic, affecting all our lives. While the virus continues its grip on the world, scientists are understanding it better and better, increasing our knowledge about it and opening up new ways to fight it.

By  Mathias Jäger

3D rendering of a human cell, attacked by a virus.

EMBLetc.

Read the latest Issues of our magazine - EMBLetc.

Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.

EMBLetc. archive

Newsletter archive

Read past editions of our monthly e-newsletter

For press

Contact the Press Office
Edit